Jacob van Naarden

Jacob van Naarden

Chief Executive Officer at LOXO ONCOLOGY INC

Net worth: 16 M $ as of 2024-03-30

39 year
Finance
Health Technology
Consumer Services

Profile

Jacob S.
van Naarden
is currently the Chief Executive Officer at Loxo Oncology, Inc. He is also the Director at Delfi Diagnostics, Inc. and the Executive Vice President at Eli Lilly & Co. Previously, he worked as an Analyst at HealthCor Management LP from 2013 to 2014.
Before that, he was an Associate at Aisling Capital LLC from 2008 to 2013.
He started his career as an Analyst at Goldman Sachs & Co. LLC from 2006 to 2008.
Mr. van Naarden completed his undergraduate degree at Princeton University in 2006.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-27 20,489 ( 0.00% ) 16 M $ 2024-03-30

Jacob van Naarden active positions

CompaniesPositionStart
LOXO ONCOLOGY INC Chief Executive Officer -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Director/Board Member 2022-06-21
All active positions of Jacob van Naarden

Former positions of Jacob van Naarden

CompaniesPositionEnd
Analyst-Equity 2014-04-30
Private Equity Analyst 2012-12-31
Analyst-Equity -
See the detail of Jacob van Naarden's experience

Training of Jacob van Naarden

Princeton University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jacob van Naarden's experience

Connections

99

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ELI LILLY AND COMPANY

Health Technology

Private companies5

Finance

Finance

Finance

Health Technology

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Jacob van Naarden